- October 30, 2017
- Posted by: admin
- Category: Updates
No Comments
Sotagliflozin, an oral anti diabetic drug, when added to insulin was found to help improve glycemic control, blood pressure and body weight in people with type 1 diabetes. However it was found to raise the risk of ketoacidosis